A tubing material change appears to be the cause of a potentially serious problem with B. Braun hemodialysis bloodline sets that the manufacturer and FDA are warning about. The FDA said B. Braun sent an urgent medical device correction to customers about its Streamline Airless System Hemodialysis Bloodlines and B3 Low Volume Bloodlines and recommended the…
The post FDA warns resin change may have caused tubing danger appeared first on Medical Design and Outsourcing.